Open Access
Pt(Iv) prodrugs with nsaids as axial ligands
Daniil Spector
1, 2
,
Olga O. Krasnovskaya
1, 2
,
Kirill G. Pavlov
2
,
Alexander Erofeev
1, 2
,
Peter Gorelkin
1, 2
,
Alexander Majouga
1, 2, 3
2
Publication type: Journal Article
Publication date: 2021-04-07
scimago Q1
wos Q1
SJR: 1.273
CiteScore: 9.0
Impact factor: 4.9
ISSN: 16616596, 14220067
PubMed ID:
33917027
Catalysis
Organic Chemistry
Inorganic Chemistry
Physical and Theoretical Chemistry
Computer Science Applications
Spectroscopy
Molecular Biology
General Medicine
Abstract
A chemo-anti-inflammatory strategy is of interest for the treatment of aggressive cancers. The platinum (IV) prodrug with non-steroidal anti-inflammatory drugs (NSAIDs) as axial ligands is designed to efficiently enter tumor cells due to high lipophilicity and release the cytotoxic metabolite and NSAID intracellularly, thereby reducing side effects and increasing the therapeutic efficacy of platinum chemotherapy. Over the last 7 years, a number of publications have been devoted to the design of such Pt(IV) prodrugs in combination with anti-inflammatory chemotherapy, with high therapeutic efficacy in vitro and In vivo. In this review, we summarize the studies devoted to the development of Pt(IV) prodrugs with NSAIDs as axial ligands, the study of the mechanism of their cytotoxic action and anti-inflammatory activity, the structure–activity ratio, and therapeutic efficacy.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Dalton Transactions
6 publications, 12.24%
|
|
|
Journal of Medicinal Chemistry
5 publications, 10.2%
|
|
|
International Journal of Molecular Sciences
3 publications, 6.12%
|
|
|
Pharmaceutics
3 publications, 6.12%
|
|
|
European Journal of Medicinal Chemistry
3 publications, 6.12%
|
|
|
Inorganics
2 publications, 4.08%
|
|
|
Molecules
2 publications, 4.08%
|
|
|
Analytical Chemistry
1 publication, 2.04%
|
|
|
ACS applied materials & interfaces
1 publication, 2.04%
|
|
|
Cancers
1 publication, 2.04%
|
|
|
ChemPhysChem
1 publication, 2.04%
|
|
|
International Journal of Nanomedicine
1 publication, 2.04%
|
|
|
Cancer Chemotherapy and Pharmacology
1 publication, 2.04%
|
|
|
Chemistry - A European Journal
1 publication, 2.04%
|
|
|
Russian Chemical Bulletin
1 publication, 2.04%
|
|
|
Russian Chemical Reviews
1 publication, 2.04%
|
|
|
Applied Sciences (Switzerland)
1 publication, 2.04%
|
|
|
Coordination Chemistry Reviews
1 publication, 2.04%
|
|
|
New Journal of Chemistry
1 publication, 2.04%
|
|
|
Journal of Molecular Structure
1 publication, 2.04%
|
|
|
Biomaterials Advances
1 publication, 2.04%
|
|
|
Russian Journal of Organic Chemistry
1 publication, 2.04%
|
|
|
Current Protein and Peptide Science
1 publication, 2.04%
|
|
|
Журнал органической химии
1 publication, 2.04%
|
|
|
Russian Journal of Oncology
1 publication, 2.04%
|
|
|
ACS Omega
1 publication, 2.04%
|
|
|
Chemistry - An Asian Journal
1 publication, 2.04%
|
|
|
Mendeleev Communications
1 publication, 2.04%
|
|
|
Biomedicines
1 publication, 2.04%
|
|
|
Journal of Inorganic Biochemistry
1 publication, 2.04%
|
|
|
1
2
3
4
5
6
|
Publishers
|
2
4
6
8
10
12
14
|
|
|
MDPI
14 publications, 28.57%
|
|
|
American Chemical Society (ACS)
8 publications, 16.33%
|
|
|
Elsevier
8 publications, 16.33%
|
|
|
Royal Society of Chemistry (RSC)
7 publications, 14.29%
|
|
|
Wiley
3 publications, 6.12%
|
|
|
Springer Nature
2 publications, 4.08%
|
|
|
Taylor & Francis
1 publication, 2.04%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 2.04%
|
|
|
Pleiades Publishing
1 publication, 2.04%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 2.04%
|
|
|
The Russian Academy of Sciences
1 publication, 2.04%
|
|
|
Eco-Vector LLC
1 publication, 2.04%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 2.04%
|
|
|
2
4
6
8
10
12
14
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
49
Total citations:
49
Citations from 2024:
18
(36%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Spector D. et al. Pt(Iv) prodrugs with nsaids as axial ligands // International Journal of Molecular Sciences. 2021. Vol. 22. No. 8. p. 3817.
GOST all authors (up to 50)
Copy
Spector D., Krasnovskaya O. O., Pavlov K. G., Erofeev A., Gorelkin P., Beloglazkina E., Majouga A. Pt(Iv) prodrugs with nsaids as axial ligands // International Journal of Molecular Sciences. 2021. Vol. 22. No. 8. p. 3817.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/ijms22083817
UR - https://www.mdpi.com/1422-0067/22/8/3817
TI - Pt(Iv) prodrugs with nsaids as axial ligands
T2 - International Journal of Molecular Sciences
AU - Spector, Daniil
AU - Krasnovskaya, Olga O.
AU - Pavlov, Kirill G.
AU - Erofeev, Alexander
AU - Gorelkin, Peter
AU - Beloglazkina, Elena
AU - Majouga, Alexander
PY - 2021
DA - 2021/04/07
PB - MDPI
SP - 3817
IS - 8
VL - 22
PMID - 33917027
SN - 1661-6596
SN - 1422-0067
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Spector,
author = {Daniil Spector and Olga O. Krasnovskaya and Kirill G. Pavlov and Alexander Erofeev and Peter Gorelkin and Elena Beloglazkina and Alexander Majouga},
title = {Pt(Iv) prodrugs with nsaids as axial ligands},
journal = {International Journal of Molecular Sciences},
year = {2021},
volume = {22},
publisher = {MDPI},
month = {apr},
url = {https://www.mdpi.com/1422-0067/22/8/3817},
number = {8},
pages = {3817},
doi = {10.3390/ijms22083817}
}
Cite this
MLA
Copy
Spector, Daniil, et al. “Pt(Iv) prodrugs with nsaids as axial ligands.” International Journal of Molecular Sciences, vol. 22, no. 8, Apr. 2021, p. 3817. https://www.mdpi.com/1422-0067/22/8/3817.